Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H5N5.H3O4P |
Molecular Weight | 233.1219 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OP(O)(O)=O.NC1=C2N=CNC2=NC=N1
InChI
InChIKey=CCHNOBQMQBSRHQ-UHFFFAOYSA-N
InChI=1S/C5H5N5.H3O4P/c6-4-3-5(9-1-7-3)10-2-8-4;1-5(2,3)4/h1-2H,(H3,6,7,8,9,10);(H3,1,2,3,4)
DescriptionSources: https://www.drugbank.ca/drugs/DB00173Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842
Sources: https://www.drugbank.ca/drugs/DB00173
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842
Adenine is a nucleobase (a purine derivative). Its derivatives have a variety of roles in biochemistry including cellular respiration, in the form of both the energy-rich adenosine triphosphate (ATP) and the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD). It also has functions in protein synthesis and as a chemical component of DNA and RNA. The shape of adenine is complementary to either thymine in DNA or uracil in RNA
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096619 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2165159 |
85.8 µM [Ki] | ||
Target ID: CHEMBL308 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9046330 |
200.0 µM [IC50] | ||
Target ID: CHEMBL1929 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17379526 |
10.89 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | LEUKOTRAP WB SYSTEM Approved UseIndicated for collection of blood and preparation of red blood cells and plasma with pre-storage leukocyte reduction. Platelet concentrates are not intended to be made with this product. |
|||
Secondary | Unknown Approved UseUnknown |
|||
Secondary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Adenine-induced selective apoptosis toward HIV chronically infected cells in vitro. | 2000 Jul 14 |
|
Influence of a probiotic yoghurt on the status of vitamins B(1), B(2) and B(6) in the healthy adult human. | 2001 |
|
A novel polymorphism (-88 C>A) in the 5' UTR of the p53R2 gene. | 2001 |
|
Molecular characterization of monoamine oxidases A and B. | 2001 |
|
Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. | 2001 Apr |
|
Quantum-chemical analysis of C-H...O and C-H...N interactions in RNA base pairs--H-bond versus anti-H-bond pattern. | 2001 Feb |
|
Mechanisms and modulation of intestinal epithelial repair. | 2001 Feb |
|
NO Inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase. | 2001 Feb |
|
De novo mutation in the mitochondrial tRNALeu(UUR) gene (A3243G) with rapid segregation resulting in MELAS in the offspring. | 2001 Feb |
|
Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target. | 2001 Feb 15 |
|
"Chemical preconditioning" by 3-nitropropionate reduces ischemia-reperfusion injury in cardiac-arrested rat lungs. | 2001 Feb 15 |
|
In situ kinetic characterization of methylthioadenosine transport by the adenosine transporter (P2) of the African Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. | 2001 Feb 15 |
|
FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated. | 2001 Feb 6 |
|
Shiga toxin 1: damage to DNA in vitro. | 2001 Feb-Mar |
|
Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells. | 2001 Jan |
|
The structure of the chloroplast F1-ATPase at 3.2 A resolution. | 2001 Jan 12 |
|
A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. | 2001 Jan 15 |
|
Oxidation of pyridine nucleotides during Fas- and ceramide-induced apoptosis in Jurkat cells: correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation. | 2001 Jan 15 |
|
2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor. | 2001 Jan 18 |
|
Selectively suppressed Ca2+-induced Ca2+ release activity of alpha-ryanodine receptor (alpha-RyR) in frog skeletal muscle sarcoplasmic reticulum: potential distinct modes in Ca2+ release between alpha- and beta-RyR. | 2001 Jan 26 |
|
Conformation and dynamics of abasic sites in DNA investigated by time-resolved fluorescence of 2-aminopurine. | 2001 Jan 30 |
|
Probing structure and dynamics of DNA with 2-aminopurine: effects of local environment on fluorescence. | 2001 Jan 30 |
|
Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA. | 2001 Jan 5 |
|
Endonuclease V of Escherichia coli prevents mutations from nitrosative deamination during nitrate/nitrite respiration. | 2001 Jan 5 |
|
Escherichia coli FtsH (HflB) degrades a membrane-associated TolAI-II-beta-lactamase fusion protein under highly denaturing conditions. | 2001 Mar |
|
cAMP-independent phosphorylation activation of CFTR by G proteins in native human sweat duct. | 2001 Mar |
|
Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data. | 2001 Mar 15 |
|
A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. | 2001 Mar 16 |
|
Expression and mutagenesis of the NqrC subunit of the NQR respiratory Na(+) pump from Vibrio cholerae with covalently attached FMN. | 2001 Mar 9 |
|
Solution structure of an A-tract DNA bend. | 2001 Mar 9 |
|
Molecular mechanism for functional interaction between DnaA protein and acidic phospholipids: identification of important amino acids. | 2001 Mar 9 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26243842
the daily dose of adenine is 10-60 mg/day
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25797921
NIH/3T3 cells were plated at a density of 2 × 106 cells and left untreated overnight, cultural media was exchanged and experimental plates were exposed to adenine (200 -1200 mkM) for 24 hr. Cells were counted at various concentration of adenine or AICAR with a hemocytometer after diluting the sample 1:1 with 0.4% trypan blue solution (Sigma-Aldrich, St. Louis, MO, USA). Alternatively, the cell cytotoxicity of the cells was monitored with XTT assay. 50 μL of XTT reagent was added and the plates were then incubated for 4 hr at 37 °C in the dark. The absorbance at 490 nm with a reference wavelength set at 690 nm using VersaMax ELISA microplate reader
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000086053
Created by
admin on Sat Dec 16 18:02:09 GMT 2023 , Edited by admin on Sat Dec 16 18:02:09 GMT 2023
|
PRIMARY | |||
|
70700-30-0
Created by
admin on Sat Dec 16 18:02:09 GMT 2023 , Edited by admin on Sat Dec 16 18:02:09 GMT 2023
|
PRIMARY | |||
|
RUT8S5GS8Z
Created by
admin on Sat Dec 16 18:02:09 GMT 2023 , Edited by admin on Sat Dec 16 18:02:09 GMT 2023
|
PRIMARY | |||
|
198277
Created by
admin on Sat Dec 16 18:02:09 GMT 2023 , Edited by admin on Sat Dec 16 18:02:09 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD